Innovative Health Plans – This website does not store your personal information or sell the information. If you submit a form, we store that information. Are you curious about cookies? Click here
Innovative Health Plans
Click on the various topic categories to find out more. You can change other settings. Please note that blocking certain types of cookies may affect your experience on our website and the services we can offer.
Digital Health Center Of Excellence
These cookies are absolutely necessary to provide the services available to you through our website and to use some of its features.
As these cookies are absolutely necessary to deliver the website, their reproduction will affect the way our website works. You can always disable or delete cookies by changing your browser settings and forcefully block all cookies on this website. But this will prompt you to accept/reject cookies when you visit our website again.
We provide you with a list of cookies stored on your computer on our site so you can see what we store. For security reasons we cannot display or edit cookies from other websites. You can check these security settings for your browser.
Technology Innovation Considerations For Healthcare Providers
Check to hide the message bar permanently and refuse all cookies if you are not logged in. We need 2 cookies to save this setting. Otherwise you will be prompted again when you open a new browser window or tab.
These cookies collect information that is used in aggregate form to help us understand how our website is used or how our marketing campaigns work, or to help us build our website and applications to improve your experience.
If you do not want us to track your visits to our website, you can Disable tracking in your browser here:
We also use external services such as Google Web Fonts, Google Maps and external video providers. Since these service providers may collect personal information such as your IP address we allow you to block them here. Please note that this may significantly reduce the functionality and appearance of our website. The change happens when you reload the pocket ultrasound device, which costs less than a 50-second hospital machine (and connects to your phone). Virtual reality accelerates healing in recovery. Artificial intelligence outperforms medical experts in detecting lung tumors. These are some of the new things that are changing medicine at an amazing rate.
Improving Care For Dually Eligible Beneficiaries Through Innovative Health Plan Partnerships
No one can predict the future, but at least it can be seen in the inventions and ideas below. Like the people behind them, they are on the front lines of health care. The list is not complete or exhaustive, rather, the list shows the transformation in public health and medical science that may come in 2020.
Since March, UPS has been running a test program called Flight Forward, using an autonomous drone to deliver medically important samples including blood or tissue between two hospital departments in Raleigh, NC, that are 150 yards apart. Walkers can cover distances nearly as fast as drones, but as a proof-of-concept system, it’s been successful, and in October the FAA gave the company permission to expand to 20 hospitals in the United States over the next two years. . “We expect that UPS Flight Forward will one day become an integral part of our company,” said David Abney, CEO of UPS, which will ship urine, blood and tissue samples, as well as medical supplies such as drugs and blood. UPS is not the only pioneer in air delivery. Wing, a division of Google’s parent company Alphabet, received similar, but more limited, licenses from the FAA to deliver goods to Walgreens and FedEx. And in Ghana and Rwanda, drones operated by Silicon Valley startup Zipline are already delivering medical supplies to rural villages. – Jeffrey Kluger
There are 7.5 billion people, and tens of millions of us monitor our health through wearable devices like smart watches, and traditional devices like blood pressure monitors. If there was a way to combine all that data from a few million of us and make it anonymous but searchable, medical researchers would have powerful tools for drug development, lifestyle studies and more. California-based Big Data Evidation developed the tool, with data from 3 million volunteers providing billions of data points. Evidence partners with drug makers such as Sanofi and Eli Lilly to share that information; Since then, the work has led to several peer-reviewed studies, on topics ranging from sleep and diet to mental health models. For founder Christine Lemke, one of Evidation’s ongoing projects, to see if new technology can accurately measure chronic pain, is personal: Lemke has a rare genetic disease that often causes back pain. Evidence is partnering with Brigham and Women’s Hospital on this project.—Jeffrey Kluger
Type 1 diabetes affects 1.25 million Americans, but two people in particular caught the attention of Harvard biologist Doug Melton: his daughter Emma and his son Sam. Treatment may include a lifestyle of careful eating, insulin injections and multiple daily blood glucose tests. Melton had a different approach: He used stem cells to create new insulin-producing beta cells. He started working 10 years ago, when stem cell research was both good and controversial. In 2014 he founded Semma Therapeutics – named after Sam and Emma – to develop the technology, and this summer it was bought by Vertex Pharmaceuticals for $950 million. The company has created a tiny implantable device that traps millions of new beta cells, allowing glucose and insulin to pass through but leaving the body’s cells out. “If it works as well in humans as it does in animals, it’s possible that people won’t get diabetes,” Melton said. “They will eat, drink, and play like we don’t drink.” – Don Steinberg
Innovations That Will Change Health Care In The 2020s
A large margin threatens to protect the era of human medicine: people of Caucasian descent are few in the world population but they spend almost 80% of subjects in human genome research, creating a blind spot in drug research. Dr. Abasi Ene-Obong, 34, founded 54gene to change that. Established in 54 African countries, the Nigerian startup is seeking genetic material from volunteers across the continent, to better research and develop medicine. 54gene knows the terrible history of colonial abuse in Africa. If the company is going to make a profit by developing a marketable drug based on the DNA of African people, Africa must benefit: therefore, when working in partnership with the company, 54gene has prioritized those who are committed to include African countries in the plan to sell any results. Drugs. “If we are part of the way to create drugs, maybe we can be part of the way to bring these drugs to Africa,” said Ene-Obong.—Corinne Purtill.
One of the first disturbances of the new economy made its way into medical research. The Parker Institute for Cancer Immunotherapy, founded by Napster-co-founder and former Facebook president Sean Parker, is a network of leading institutions including Memorial Sloan Kettering, Stanford, MD Anderson Cancer Center and others. It aims to identify and remove barriers to innovation in traditional research. For example, each participating center agreed to receive an approval decision from any institutional review board, “allowing us to start large clinical trials in weeks instead of years,” Parker said, and lower costs. . Perhaps most importantly, Parker wants to infuse the program with his marketing sensibilities: “We follow the findings of our researchers and put our money behind them for commercialization,” he said. . Since its establishment in 2016, the organization has brought 11 projects to clinical trials and supported approximately 2,000 research papers.
A man wearing a black wristwatch is watching a small dinosaur jump over an obstacle in front of him on a computer. The man’s hand is still, but he controls the dinosaur – with his brain. The device on his wrist is a CTRL set, which detects electrical impulses traveling from motor neurons down the muscles of the arm to the hand almost as fast as a person thinks about a certain movement. “I want machines to do what we want them to do, and I want us not to be stuck on machines,” said Thomas Reardon, CEO and founder of CTRL-Labs, a tool maker. The mass movement and annoying keys of the smartphone era represent “a step backwards for society,” Reardon, a neuroscientist, in .